Uni-Bio Science Group Limited
UNBSF
$0.004
$0.000.00%
OTC PK
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 4.31M | 4.31M | 2.01M | 2.01M | 2.51M |
| Total Depreciation and Amortization | 698.80K | 698.60K | 556.70K | 556.00K | 493.80K |
| Total Amortization of Deferred Charges | -- | -- | 28.10K | 28.10K | -- |
| Total Other Non-Cash Items | -1.55M | -1.55M | 1.20M | 1.20M | -1.07M |
| Change in Net Operating Assets | -- | -- | 581.10K | 580.30K | -- |
| Cash from Operations | 3.46M | 3.46M | 4.38M | 4.38M | 1.94M |
| Capital Expenditure | -- | -- | -3.82M | -3.82M | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -2.29M | -2.29M | 212.10K | 211.80K | -1.26M |
| Cash from Investing | -2.29M | -2.29M | -3.61M | -3.61M | -1.26M |
| Total Debt Issued | -- | -- | 22.83M | 22.83M | -- |
| Total Debt Repaid | -- | -- | -7.52M | -7.52M | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -2.58M | -2.58M | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 12.66M | 12.66M | -792.00K | -792.00K | 321.50K |
| Cash from Financing | 1.62M | 1.62M | 1.53M | 1.53M | 41.00K |
| Foreign Exchange rate Adjustments | -1.21M | -1.21M | -162.10K | -161.90K | -871.60K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.58M | 1.58M | 2.14M | 2.13M | -152.00K |